Silo Pharma, Inc. (SILO)
Develops psychedelic and ketamine treatments for PTSD, anxiety, fibromyalgia, and neurological diseases
$4.46+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-59.0%
The outlook
SILO trades at $4.46, near its 52-week lows and below both its 50- and 200-day moving averages, reflecting downward momentum. Analyst coverage appears minimal based on available data. The overall sentiment leans bearish, with the stock positioned in the lower part of its recent range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$5.0M
52-wk high
$15.15
52-wk low
$3.32
50-day avg
$5.77
200-day avg
$6.12
Trailing P/E
—